Proteomic profiling reveals immunomodulatory role of IL-33 in ocular bacterial and fungal infections
Open Access
- 13 June 2025
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 93 (7) , e0018325
Abstract
Bacterial and fungal pathogens are major causes of infectious endophthalmitis following eye surgery or trauma, often leading to vision impairment or blindness. The distinct clinical outcomes observed in bacterial and fungal endophthalmitis suggest differences in host immune responses. To investigate these differences, we utilized cytokine arrays and murine models of bacterial ( Staphylococcus aureus ) and fungal ( Aspergillus fumigatus ) endophthalmitis. Our analysis revealed that cytokine responses peaked in bacterial infections at 12–24 h, whereas fungal infections exhibited a delayed peak at 48 h. Several inflammatory mediators, including MMP9, MMP3, CD14, LIX, LCN2, retinol-binding protein 4, ICAM1, and VCAM1, were differentially elevated. Notably, interleukin-33 (IL-33) levels peaked early in bacterial infections but continued to rise throughout all time points in fungal endophthalmitis. Analysis of patient vitreous samples further confirmed higher levels of IL-33 in bacterial ( n =40) and fungal ( n =20) endophthalmitis cases. Functional studies in IL-33-deficient mice revealed an increased fungal burden and elevated TNF-α and IL-6 levels, but bacterial endophthalmitis severity remains largely unaffected. Additionally, bone marrow-derived macrophages from IL-33 −/− mice exhibited increased cell death in response to fungal and bacterial infection. Our findings reveal divergent innate immune responses between bacterial and fungal endophthalmitis and emphasize the immunomodulatory function of IL-33 in ocular infections.Keywords
Funding Information
- National Eye Institute (P30EY004068)
- National Institutes of Health (R01EY026964)
- National Institutes of Health (R01EY027381)
- National Institutes of Health (R01EY035499)
This publication has 73 references indexed in Scilit:
- The IL-33/ST2 Axis Protects Retinal Ganglion Cells by Modulating the Astrocyte Response After Optic Nerve InjuryNeuroscience Bulletin, 2024
- Oral administration of S-nitroso-l-glutathione (GSNO) provides anti-inflammatory and cytoprotective effects during ocular bacterial infectionsCellular and Molecular Life Sciences, 2023
- Signaling and functions of interleukin-33 in immune regulation and diseasesCell Insight, 2022
- Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokineCytokine, 2022
- The Role of Systemic Antimicrobials in the Treatment of Endophthalmitis: A Review and an International PerspectiveOphthalmology and Therapy, 2020
- Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibioticsClinical Microbiology and Infection, 2019
- Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedureCochrane Database of Systematic Reviews, 2017
- DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammationEuropean Journal of Pharmacology, 2016
- IL‐33 attenuates the development of experimental autoimmune uveitisEuropean Journal of Immunology, 2014
- Role of heparan sulfate in ocular diseasesExperimental Eye Research, 2013